Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other Non-Current Liabilities (2023 - 2025)

Profound Medical has reported Other Non-Current Liabilities over the past 3 years, most recently at $79000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $79000.0 for Q4 2025, up 11.27% from a year ago — trailing twelve months through Dec 2025 was $79000.0 (up 11.27% YoY), and the annual figure for FY2025 was $79000.0, up 11.27%.
  • Other Non-Current Liabilities for Q4 2025 was $79000.0 at Profound Medical, up from $76000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for PROF hit a ceiling of $79000.0 in Q4 2025 and a floor of $71000.0 in Q4 2024.
  • Median Other Non-Current Liabilities over the past 3 years was $74500.0 (2023), compared with a mean of $74666.7.
  • Biggest five-year swings in Other Non-Current Liabilities: decreased 2.74% in 2024 and later rose 11.27% in 2025.
  • Profound Medical's Other Non-Current Liabilities stood at $73000.0 in 2023, then decreased by 2.74% to $71000.0 in 2024, then rose by 11.27% to $79000.0 in 2025.
  • The last three reported values for Other Non-Current Liabilities were $79000.0 (Q4 2025), $76000.0 (Q3 2025), and $77000.0 (Q2 2025) per Business Quant data.